Welcome to LookChem.com Sign In|Join Free

CAS

  • or
KAEMPFEROL-3-GLUCURONIDE is a kaempferol O-glucuronide, which is a flavonoid compound with a beta-D-glucosiduronic acid residue attached at the 3-position. It is a naturally occurring compound found in various plants and is known for its potential health benefits and applications in different industries.

22688-78-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 22688-78-4 Structure
  • Basic information

    1. Product Name: KAEMPFEROL-3-GLUCURONIDE
    2. Synonyms: 3-(β-D-Glucopyranuronosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;3-(β-D-Glucurono pyranosyloxy)-5,7,4'-trihydroxyflavone;4',5,7-Trihydroxyflavon-3-yl β-D-glucopyranosiduronic acid;Kaempferol 3-O-β-D-glucuronopyranoside;5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl-beta-D-glucopyranosiduronic acid;Kaempferol-3-beta-O-glucuronide;Kaempferol 3-O-β-D-glucuronide
    3. CAS NO:22688-78-4
    4. Molecular Formula: C21H18O12
    5. Molecular Weight: 462.36
    6. EINECS: N/A
    7. Product Categories: Miscellaneous Natural Products;reagent;standard substance
    8. Mol File: 22688-78-4.mol
  • Chemical Properties

    1. Melting Point: 189-191 °C
    2. Boiling Point: 876.8 °C at 760 mmHg
    3. Flash Point: 309.8 °C
    4. Appearance: /
    5. Density: 1.87
    6. Vapor Pressure: 6.85E-33mmHg at 25°C
    7. Refractive Index: 1.788
    8. Storage Temp.: ?20°C
    9. Solubility: N/A
    10. PKA: 2.76±0.70(Predicted)
    11. CAS DataBase Reference: KAEMPFEROL-3-GLUCURONIDE(CAS DataBase Reference)
    12. NIST Chemistry Reference: KAEMPFEROL-3-GLUCURONIDE(22688-78-4)
    13. EPA Substance Registry System: KAEMPFEROL-3-GLUCURONIDE(22688-78-4)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 22688-78-4(Hazardous Substances Data)

22688-78-4 Usage

Uses

Used in Pharmaceutical Industry:
KAEMPFEROL-3-GLUCURONIDE is used as a bioactive compound for its potential therapeutic properties. It has been studied for its antioxidant, anti-inflammatory, and anti-cancer activities, making it a promising candidate for the development of new drugs and treatments.
Used in Cosmetic Industry:
In the cosmetic industry, KAEMPFEROL-3-GLUCURONIDE is used as an ingredient in skincare products for its antioxidant and anti-inflammatory properties. It may help protect the skin from environmental stressors and promote a healthy, youthful appearance.
Used in Functional Foods and Supplements:
KAEMPFEROL-3-GLUCURONIDE is also used as an additive in the functional foods and dietary supplements industry due to its potential health benefits. It can be found in products that aim to support overall health and well-being, particularly in relation to inflammation and oxidative stress.
Used in Research and Development:
KAEMPFEROL-3-GLUCURONIDE is utilized in research and development for its potential applications in various fields, including pharmaceuticals, cosmetics, and functional foods. Scientists are continually exploring its properties and potential uses to better understand its benefits and optimize its applications.

Check Digit Verification of cas no

The CAS Registry Mumber 22688-78-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,6,8 and 8 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 22688-78:
(7*2)+(6*2)+(5*6)+(4*8)+(3*8)+(2*7)+(1*8)=134
134 % 10 = 4
So 22688-78-4 is a valid CAS Registry Number.
InChI:InChI=1/C21H18O12/c22-8-3-1-7(2-4-8)17-18(13(25)12-10(24)5-9(23)6-11(12)31-17)32-21-16(28)14(26)15(27)19(33-21)20(29)30/h1-6,14-16,19,21-24,26-28H,(H,29,30)/t14-,15-,16+,19-,21?/m0/s1

22688-78-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names Kaempferol 3-glucuronide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22688-78-4 SDS

22688-78-4Relevant articles and documents

FLAVONOIDS OF THE FLOWERS OF TAMARIX NILOTICA

Nawwar, M. A. M.,Souleman, A. M. A.,Buddrus, J.,Linscheid, M.

, p. 2347 - 2350 (1984)

The ethyl ester of kaempferol 3-O-β-D-glucuronide, the methyl and ethyl esters of quercetin 3-O-β-D-glucuronide have been isolated from an aqueous acetone extract of the flowers of Tamarix nilotica.In addition kaempferol 3-O-sulphate-7,4'-dimethyl ether and the free aglycones were isolated.The structures were established by routine methods, by FAB-MS and by 13C NMR spectral measurements. - Key Word Index: Tamarix nilotica; Tamaricaceae; flowers; kaempferol 3-O-β-D-glucuronide 6''-ethyl ester; quercetin 3-O-β-D-glucuronide 6''-methyl ester; quercetin 3-O-β-D-glucuronide 6''-ethyl ester; kaempferol 3-O-sulphate-7,4'-dimethyl ether.

Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol

Li, Yuhuan,Lu, Linlin,Wang, Liping,Qu, Wei,Liu, Wenqin,Xie, Yushan,Zheng, Hongming,Wang, Ying,Qi, Xiaoxiao,Hu, Ming,Zhu, Lijun,Liu, Zhongqiu

, p. 5602 - 5614 (2018)

Glucuronidation is a major process of drug metabolism and elimination that generally governs drug efficacy and toxicity. Publications have demonstrated that efflux transporters control intracellular glucuronidation metabolism. However, it is still unclear whether and how efflux transporters interact with UDP-glucuronosyltransferases (UGTs) in subcellular organelles. In this study, kaempferol, a model fluorescent flavonoid, was used to investigate the interplay of glucuronidation with transport at the subcellular level. Human recombinant UGTs and microsomes were utilized to characterize the in vitro glucuronidation kinetics of kaempferol. The inhibition of UGTs and efflux transporters on the subcellular disposition of kaempferol were determined visually and quantitatively in Caco-2/TC7 cells. The knockout of transporters on the subcellular accumulation of kaempferol in liver and intestine were evaluated visually. ROS and Nrf2 were assayed to evaluate the pharmacological activities of kaempferol. The results showed that UGT1A9 is the primary enzyme responsible for kaempferol glucuronidation. Visual and quantitative data showed that the UGT1A9 inhibitor carvacrol caused a significant rise in subcellular aglycone and reduction in subcellular glucuronides of kaempferol. The inhibition and knockout of transporters, such as P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and multidrug resistance-associated proteins (MRPs), exhibited a marked increase in subcellular kaempferol and decrease in its subcellular glucuronides. Correspondingly, inhibition of UGT1A9 and transporters led to increased kaempferol and, consequently, a significantly enhanced ROS scavenging efficiency and nuclear translocation of Nrf2. In conclusion, the interplay of efflux transporters (P-gp, BCRP, and MRPs) and UGTs govern the subcellular exposure and corresponding pharmacological activity of kaempferol.

Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches

Wu, Baojian,Wang, Xiaoqiang,Zhang, Shuxing,Hu, Ming

experimental part, p. 1544 - 1561 (2012/07/27)

Purpose: Catalytic selectivity of human UGT1A9, an important membrane-bound enzyme catalyzing glucuronidation of xenobiotics, was determined experimentally using 145 phenolics and analyzed by 3D-QSAR methods. Methods: Catalytic efficiency of UGT1A9 was determined by kinetic profiling. Quantitative structure activity relationships were analyzed using CoMFA and CoMSIA techniques. Molecular alignment of substrate structures was made by superimposing the glucuronidation site and its adjacent aromatic ring to achieve maximal steric overlap. For a substrate with multiple active glucuronidation sites, each site was considered a separate substrate. Results: 3D-QSAR analyses produced statistically reliable models with good predictive power (CoMFA: q 2=0.548, r2=0.949, r pred 2 =0.775; CoMSIA: q2=0.579, r2=0.876, rpred2 =0.700). Contour coefficient maps were applied to elucidate structural features among substrates that are responsible for selectivity differences. Contour coefficient maps were overlaid in the catalytic pocket of a homology model of UGT1A9, enabling identification of the UGT1A9 catalytic pocket with a high degree of confidence. Conclusion: CoMFA/CoMSIA models can predict substrate selectivity and in vitro clearance of UGT1A9. Our findings also provide a possible molecular basis for understanding UGT1A9 functions and substrate selectivity.

Regioselective glucuronidation of flavonols by six human UGT1A isoforms

Wu, Baojian,Xu, Beibei,Hu, Ming

experimental part, p. 1905 - 1918 (2012/05/07)

Purpose: Glucuronidation is a major barrier to flavonoid bioavailability; understanding its regiospecificity and reaction kinetics would greatly enhance our ability to model and predict flavonoid disposition. We aimed to determine the regioselective glucuronidation of four model flavonols using six expressed human UGT1A isoforms (UGT1A1, 1A3, 1A7, 1A8, 1A9, 1A10). Methods: In vitro reaction kinetic profiles of six UGT1A-mediated metabolism of four flavonols (all with 7-OH group) were characterized; kinetic parameters (Km, Vmax and CLint∈=∈Vmax/Km) were determined. Results: UGT1A1 and 1A3 regioselectively metabolized the 7-OH group, whereas UGT1A7, 1A8, 1A9 and 1A10 preferred to glucuronidate the 3-OH group. UGT1A1 and 1A9 were the most efficient conjugating enzymes with K m values of 1 μM and relative catalytic efficiency ratios of 5.5. Glucuronidation by UGT1As displayed surprisingly strong substrate inhibition. In particular, Ksi values (substrate inhibition constant) were less than 5.4 μM for UGT1A1-mediated metabolism. Conclusion: UGT1A isoforms displayed distinct positional preferences between 3-OH and 7-OH of flavonols. Differentiated kinetic properties between 3-O- and 7-O- glucuronidation suggested that (at least) two distinct binding modes within the catalytic domain were possible. The existence of multiple binding modes should provide better "expert" knowledge to model and predict UGT1A-mediated glucuronidation.

Three-dimensional quantitative structure-activity relationship studies on UGT1A9-mediated 3-O-glucuronidation of natural flavonols using a pharmacophore-based comparative molecular field analysis model

Wu, Baojian,Morrow, John Kenneth,Singh, Rashim,Zhang, Shuxing,Hu, Ming

experimental part, p. 403 - 413 (2011/12/16)

Glucuronidation is often recognized as one of the rate-determining factors that limit the bioavailability of flavonols. Hence, design and synthesis of more bioavailable flavonols would benefit from the establishment of predictive models of glucuronidation using kinetic parameters [e.g., Km, V max, intrinsic clearance (CLint) = Vmax/K m] derived for flavonols. This article aims to construct position (3-OH)-specific comparative molecular field analysis (CoMFA) models to describe UDP-glucuronosyltransferase (UGT) 1A9-mediated glucuronidation of flavonols, which can be used to design poor UGT1A9 substrates. The kinetics of recombinant UGT1A9-mediated 3-O-glucuronidation of 30 flavonols was characterized, and kinetic parameters (Km, Vmax, CLint) were obtained. The observed Km, Vmax, and CLint values of 3-O-glucuronidation ranged from 0.04 to 0.68 μM, 0.04 to 12.95 nmol/mg/min, and 0.06 to 109.60 ml/mg/min, respectively. To model UGT1A9-mediated glucuronidation, 30 flavonols were split into the training (23 compounds) and test (7 compounds) sets. These flavonols were then aligned by mapping the flavonols to specific common feature pharmacophores, which were used to construct CoMFA models of Vmax and CLint, respectively. The derived CoMFA models possessed good internal and external consistency and showed statistical significance and substantive predictive abilities (Vmax model: q2 = 0.738, r2 = 0.976, rpred2 = 0.735; CLint model: q2 = 0.561, r2 = 0.938, rpred2 = 0.630). The contour maps derived from CoMFA modeling clearly indicate structural characteristics associated with rapid or slow 3-O-glucuronidation. In conclusion, the approach of coupling CoMFA analysis with a pharmacophore-based structural alignment is viable for constructing a predictive model for regiospecific glucuronidation rates of flavonols by UGT1A9. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 22688-78-4